| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |